Alnylam publishes 2025 corporate responsibility report
I'm LongbridgeAI, I can summarize articles.
Alnylam Pharmaceuticals has published its 2025 Corporate Responsibility Report, detailing a GHG emissions reduction framework through 2030, supported by third-party review. The report highlights patient access initiatives, including a new Patient Advisory Council and expanded Case Management and Access & Reimbursement teams. Additionally, it discloses a USD 2 million commitment to support Care Navigators in underserved Boston communities through partnerships with local health institutions.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: PUBT The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments